TNF and infection: When summarizing the existing data in this systematic review, no association between treatment with TNF-α inhibitors for IBD in pregnancy and adverse pregnancy outcomes such as spontaneous abortions, preterm deliveries, stillbirth, low birth weight, congenital malformations, and/or infections, was found, even after administration of TNF-α blockers in the third trimester.